Results 1 to 10 of about 696,648 (168)

PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naïve type 2 diabetes mellitus patients

open access: yesFrontiers in Pharmacology, 2023
Objective: PB-119, a PEGylated exenatide injection, is a once-weekly glucagon-like peptide-1 receptor agonist. In the present study, we aimed to evaluate the effects of PB-119 on insulin resistance and beta-cell function in Chinese patients with type 2 ...
Xu Liu   +15 more
doaj   +1 more source

WNT ligands in non-small cell lung cancer: from pathogenesis to clinical practice

open access: yesDiscover Oncology, 2023
Non-small cell lung cancer (NSCLC) is the malignant tumor with the highest morbidity and leading cause of death worldwide, whereas its pathogenesis has not been fully elucidated.
Wanting Xue   +7 more
doaj   +1 more source

Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease

open access: yesFrontiers in Pharmacology, 2022
The global incidence rate of non-alcoholic fatty liver disease (NAFLD) is approximately 25%. With the global increase in obesity and its associated metabolic syndromes, NAFLD has become an important cause of chronic liver disease in many countries ...
Yajie Fu   +12 more
doaj   +1 more source

Role of G-protein coupled receptors in cardiovascular diseases

open access: yesFrontiers in Cardiovascular Medicine, 2023
Cardiovascular diseases (CVDs) are the leading cause of death globally, with CVDs accounting for nearly 30% of deaths worldwide each year. G-protein-coupled receptors (GPCRs) are the most prominent family of receptors on the cell surface, and play an ...
Yuanqiang Li   +4 more
doaj   +1 more source

Emerging Roles of Wnt Ligands in Human Colorectal Cancer

open access: yesFrontiers in Oncology, 2020
Colorectal cancer (CRC) is the fourth leading cause of cancer death worldwide, and constitutive activation of the Wnt signaling pathway is universal in most CRC cases.
Xiaobo Nie   +5 more
doaj   +1 more source

The Apelin/APJ System in Psychosis and Neuropathy

open access: yesFrontiers in Pharmacology, 2020
Apelin, an endogenous neuropeptide, has been identified as the cognate ligand for the G-protein-coupled receptor APJ. Apelin, APJ messenger RNA, and protein are widely expressed in the central nervous system and peripheral tissues of humans and animals ...
Shuang-Yu Lv   +3 more
doaj   +1 more source

Downregulation of Wnt3 Suppresses Colorectal Cancer Development Through Inhibiting Cell Proliferation and Migration

open access: yesFrontiers in Pharmacology, 2019
The aberrant expression of Wnt3 has linked to several types of human malignancies. However, it is not known for its role in tumorigenesis of colorectal cancer (CRC).
Xiaobo Nie   +13 more
doaj   +1 more source

Emerging Roles of NPQ/Spexin in Physiology and Pathology

open access: yesFrontiers in Pharmacology, 2019
Spexin (SPX), also called neuropeptide Q (NPQ), is a novel endogenous neuropeptide. Spexin gene and protein are widely expressed in central nervous system and peripheral tissues in humans, rodents, goldfish, etc.
Shuang-Yu Lv   +5 more
doaj   +1 more source

The Role of the Apelin/APJ System in the Regulation of Liver Disease

open access: yesFrontiers in Pharmacology, 2017
Apelin is an endogenous peptide that is a ligand for the APJ receptor (angiotensin II receptor like-1, AT-1). The apelin/APJ system is distributed in diverse periphery organ tissues.
Wei-Dong Chen   +4 more
doaj   +1 more source

Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism

open access: yeseLife, 2020
By analyzing and simulating inactive conformations of the highly homologous dopamine D2 and D3 receptors (D2R and D3R), we find that eticlopride binds D2R in a pose very similar to that in the D3R/eticlopride structure but incompatible with the D2R ...
J Robert Lane   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy